Renaissance Technologies’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196K | Buy |
89,913
+13,090
| +17% | +$28.5K | ﹤0.01% | 3175 |
|
|
2025
Q1 | $92.2K | Buy |
76,823
+1,400
| +2% | +$1.68K | ﹤0.01% | 3210 |
|
|
2024
Q4 | $128K | Buy |
75,423
+700
| +0.9% | +$1.19K | ﹤0.01% | 3247 |
|
|
2024
Q3 | $176K | Buy |
74,723
+600
| +0.8% | +$1.41K | ﹤0.01% | 3151 |
|
|
2024
Q2 | $216K | Buy |
74,123
+2,800
| +4% | +$8.18K | ﹤0.01% | 3022 |
|
|
2024
Q1 | $217K | Buy |
71,323
+2,400
| +3% | +$7.3K | ﹤0.01% | 3201 |
|
|
2023
Q4 | $196K | Buy |
68,923
+8,200
| +14% | +$23.3K | ﹤0.01% | 3139 |
|
|
2023
Q3 | $164K | Buy |
60,723
+3,400
| +6% | +$9.18K | ﹤0.01% | 3134 |
|
|
2023
Q2 | $92K | Buy |
57,323
+7,700
| +16% | +$12.4K | ﹤0.01% | 3495 |
|
|
2023
Q1 | $111K | Sell |
49,623
-57,416
| -54% | -$128K | ﹤0.01% | 3458 |
|
|
2022
Q4 | $405K | Buy |
107,039
+19,663
| +23% | +$74.4K | ﹤0.01% | 3066 |
|
|
2022
Q3 | $323K | Buy |
87,376
+34,587
| +66% | +$128K | ﹤0.01% | 3182 |
|
|
2022
Q2 | $728K | Buy |
52,789
+14,516
| +38% | +$200K | ﹤0.01% | 2911 |
|
|
2022
Q1 | $827K | Buy |
38,273
+5,020
| +15% | +$108K | ﹤0.01% | 2854 |
|
|
2021
Q4 | $898K | Buy |
33,253
+223
| +0.7% | +$6.02K | ﹤0.01% | 2726 |
|
|
2021
Q3 | $1.9M | Buy |
33,030
+9,162
| +38% | +$528K | ﹤0.01% | 2129 |
|
|
2021
Q2 | $2.39M | Buy |
23,868
+17,342
| +266% | +$1.74M | ﹤0.01% | 2141 |
|
|
2021
Q1 | $992K | Buy |
+6,526
| New | +$992K | ﹤0.01% | 2611 |
|
|
2020
Q3 | – | Sell |
-330
| Closed | -$94K | – | 3369 |
|
|
2020
Q2 | $94K | Sell |
330
-1,198
| -78% | -$341K | ﹤0.01% | 3288 |
|
|
2020
Q1 | $458K | Buy |
+1,528
| New | +$458K | ﹤0.01% | 2799 |
|
|
2019
Q1 | – | Sell |
-476
| Closed | -$75K | – | 3445 |
|
|
2018
Q4 | $75K | Buy |
476
+393
| +473% | +$61.9K | ﹤0.01% | 3260 |
|
|
2018
Q3 | $46K | Buy |
+83
| New | +$46K | ﹤0.01% | 3288 |
|